Live feed08:00:00·4dPRReleasevia QuantisnowAbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia AreataByQuantisnow·Wall Street's wire, on your screen.ABBV· AbbVie Inc.Health Care
